NIAID-supported study examines vulnerability of gonorrhea to older antibiotic drug

(NIH/National Institute of Allergy and Infectious Diseases) A new clinical research study seeks to determine whether a rapid molecular diagnostic test can reliably identify gonorrhea infections that may be treated with a single dose of an older antibiotic, ciprofloxacin. The study will enroll up to 381 men and women diagnosed with untreated Neisseria gonorrhoeae. It is sponsored by the National Institute of Allergy and Infectious Diseases and is being conducted by the NIAID-funded Sexually Trans...